Post Marketing Surveillance Study of Actimmune in Patients With Severe, Malignant Osteopetrosis
Post-Marketing Surveillance Study of Actimmune (Interferon Gamma-1b) in Patients With Severe Malignant Osteopetrosis Post-Marketing Surveillance Study of Actimmune (Interferon Gamma-1b) in Patients With Severe Maligna ...